Dr. Monsour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1308 Paluxy Rd
Ste 300
Granbury, TX 76048Phone+1 817-579-3902Fax+1 817-579-3901
Education & Training
- University of Nebraska Medical Center College of MedicineFellowship, Transplant Hepatology, 1991 - 1992
- University of Nebraska Medical Center College of MedicineFellowship, Gastroenterology, 1987 - 1989
- University of Nebraska Medical Center College of MedicineChief Residency, Internal Medicine/Pediatrics, 1986 - 1987
- University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1983 - 1986
- Universidad de GuadalajaraClass of 1981
Certifications & Licensure
- MO State Medical License 2022 - 2024
- PA State Medical License 1989 - 2024
- TX State Medical License 1992 - 2024
- KS State Medical License 2021 - 2023
- SC State Medical License 2022 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- TOP DOCs Houstons Top Medical Professionals (Peer Nomination) Houston Magazine
Clinical Trials
- Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Start of enrollment: 2013 Apr 03
Publications & Presentations
PubMed
- 693 citationsHepatocellular carcinoma: a reviewJulius Balogh, David W. Victor, Emad H. Asham, Sherilyn Gordon Burroughs, Maha Boktour
Journal of Hepatocellular Carcinoma. 2016-10-05 - 16 citationsElevation of chemotactic factor inactivator in alcoholic liver disease.Richard A. Robbins, Rowen K. Zetterman, Todd J. Kendall, Gail L. Gossman, Howard Paul Monsour
Hepatology. 1987-09-01 - 66 citationsElbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4–5 chronic kidney disease: clinical, virological, and health-related quality-of-life ...Annette Bruchfeld, David Roth, Paul J. Martin, David R. Nelson, Stanislas Pol
The Lancet. Gastroenterology & Hepatology. 2017-08-01
Press Mentions
- VIDEO: Genetic Testing Identifies Patients at Increased Risk for Cancers, PancreatitisJune 8th, 2022
- Liver Cancer Is Affecting Hispanics at an Alarming Rate in TexasMay 7th, 2014
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: